Common injection site reactions include redness at the injection site, mild pain or tenderness, swelling around the injection area, itching or irritation, and bruising if the needle accidentally punctures a small blood vessel
If it does not, that is a flag to look for other causes (kidney function, MTHFR genetic variants, certain medications)
Off-label use = uncontrolled variables Were seeing increasing use in populations: Outside licensed BMI thresholds Without comorbidity Without ongoing clinical monitoring This creates a perfect storm: Dose escalation without supervision Poor management of GI side effects No medication reconciliation (often overlooked) And this is where things start to get clinically interesting The hidden interaction risk: oral medications GLP-1s dont just act on appetite
Lower visceral fat = lower aromatase activity = more free testosterone
Jul 25, 2025 If you have noticed a number of celebrities losing weight quickly, particularly in the American market, there is a strong possibility that a new family of drug known as GLP-1 agonists are responsible